Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic ApplicationsNiaz Mahmood, Shafaat A. Rabbani|Frontiers in Oncology|2018Cited by 479
A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis <i>in vivo</i>Parisa Khalili, Shafaat A. Rabbani|Molecular Cancer Therapeutics|2006Cited by 197
Alteration of the Methylation Status of Tumor-Promoting Genes Decreases Prostate Cancer Cell Invasiveness and Tumorigenesis <i>In vitro</i> and <i>In vivo</i>Nicholas Shukeir, Shafaat A. Rabbani|Cancer Research|2006Cited by 155
DNA Methylation Readers and Cancer: Mechanistic and Therapeutic ApplicationsNiaz Mahmood, Shafaat A. Rabbani|Frontiers in Oncology|2019Cited by 118
Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transitionNiaz Mahmood, Shafaat A. Rabbani|Experimental & Molecular Medicine|2024Cited by 13